New effects of diabetes medicine

Recently, a group of Taiwanese medical researchers has discovered the positive response of Rosiglitazone to the treatment of patients with cerebral hemorrhagic stroke.

Experts from Taiwan's Medical Research Institute said Rosiglitazone has a function to significantly reduce the incidence of necrosis of brain cells, as well as reduce the amount of nerve tissue destroyed when a stroke occurs. Cerebral hemorrhagic stroke.

Normally, when a patient has a cerebral hemorrhage, blood vessels will not provide blood to the brain, causing brain and nerve tissue cells to be destroyed, causing cardiovascular disease.

These results have been tested by testing on mice. According to Taiwan's Medical Research Institute, the best time to inject Rosiglitazone effectively is within 2 hours of the stroke. The institute is planning to coordinate with other medical research institutes to conduct the next phase of clinical trials.